Thus, elevated level of IL-6 is pathognomonic sign of inflammation and drugs like Tocilizumab (Actemra) that target IL-6 and/or IL-6R are effective and approved for the treatment of autoimmune diseases including rheumatoid arthritis (27). Here, IL6 is linked to autoimmune disease.